Emergent Biosolutions Inc. (EBS) vs Tilray Brands, Inc. (TLRY)
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
- Tilray Brands, Inc. TLRY 3.04 −5.30%
Emergent Biosolutions Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $474.4M against $368.1M — 1.3× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against −9.56%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −23.0%) and the higher return on invested capital (−3.21% vs −5.27%). Across the 19 metrics below, Tilray Brands, Inc. leads on 12 and Emergent Biosolutions Inc. on 7.
Valuation
Profitability
| Metric | EBS | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.87% | 29.12% | 53.94% |
| Operating margin | (8.57%) | (9.26%) | 0.00% |
| Net margin | (22.96%) | (17.05%) | 0.00% |
| Free cash flow margin | 11.18% | (18.11%) | 0.00% |
| Return on equity | (40.29%) | (10.50%) | (0.40%) |
| Return on assets | (13.95%) | (7.45%) | (3.32%) |
| Return on invested capital | (5.27%) | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack